Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

CTSO STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024
May 09, 2024 16:17 ET | Source: CytoSorbents

CytoSorbents Reports First Quarter 2024 Results

CytoSorbents Reports First Quarter 2024 Results
May 02, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

CytoSorbents to Host Virtual KOL and Analyst-Investor Day on May 6, 2024 to review U.S. and Canada STAR-T Pivotal Trial Topline Results
April 26, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

CytoSorbents to Report First Quarter 2024 Operating and Financial Results
April 17, 2024 07:00 ET | Source: CytoSorbents

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
March 14, 2024 16:39 ET | Source: CytoSorbents

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results

CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 06, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents to Report Fiscal 2023 Operating and Financial Results

PRINCETON, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery...
February 08, 2024 07:00 ET | Source: CytoSorbents

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference

CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference
December 28, 2023 07:00 ET | Source: CytoSorbents

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

CytoSorbents Provides Update on STAR-T Trial and Final Independent DSMB Recommendation
December 13, 2023 09:15 ET | Source: CytoSorbents

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

CytoSorbents Strengthens Balance Sheet with $10.3M Registered Direct Offering. Insiders invest $435,000

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right